Oncogenic mutations produce similar phenotypes in Drosophila tissues of diverse origins
1Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309-0347, USA.
Abstract:
An emerging interest in oncology is to tailor treatment to particular cancer genotypes, i.e. oncogenic mutations present in the tumor, and not the tissue of cancer incidence. Integral to such a practice is the idea that the same oncogenic mutation(s) produces similar outcomes in different tissues. To test this idea experimentally, we studied tumors driven by a combination of Ras(V12) and scrib(1) mutations in Drosophila larvae. We found that tumors induced in tissues of neural ectodermal and mesodermal origins behaved similarly in every manner examined: cell cycle checkpoints, apoptosis, cellular morphology, increased aneuploidy and response to Taxol. We conclude that oncogenic effects override tissue-specific differences, at least for the mutations, tissues, and phenotypes studied herein.
Insights
Targeted cancer therapy based on tumor genetics shows promise. Oncogenic mutations, like Ras(V12) and scrib(1), drive similar tumor behaviors across different tissues in Drosophila, overriding tissue-specific effects.
Area of Science:
- Oncology
- Genetics
- Developmental Biology
Background:
- Precision oncology aims to match cancer treatments to specific tumor genotypes.
- A key assumption is that identical oncogenic mutations yield similar outcomes regardless of tissue origin.
Purpose of the Study:
- To experimentally validate if oncogenic mutations induce comparable tumor phenotypes across diverse tissue types.
- Investigating the influence of genetic mutations versus tissue origin in cancer development.
Main Methods:
- Utilized Drosophila melanogaster larvae as a model system.
- Induced tumors using a combination of Ras(V12) and scrib(1) mutations.
- Analyzed tumor behavior in neural ectodermal and mesodermal tissues.
Main Results:
- Tumors in different tissues exhibited remarkably similar characteristics.
- Observed consistent behavior in cell cycle checkpoints, apoptosis, and cellular morphology.
- Both tumor types showed increased aneuploidy and comparable responses to Taxol treatment.
Conclusions:
- Oncogenic mutations can override intrinsic tissue-specific differences in tumor behavior.
- Findings support the genotype-driven approach in cancer treatment, irrespective of tissue of origin.
- The study provides experimental evidence for the universality of certain oncogenic mutation effects.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
The Ras Gene
Ras is a...


